| Company Name: |
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
|
| Tel: |
4000862158 18117107507 |
| Email: |
vip@med-life.cn |
| Products Intro: |
Cas:665-66-7
ProductName:Amantadine HCl
Purity: >=98% | Package: 10mM (in 1mL DMSO);50g;10g
|
| Company Name: |
Wuxi Hailun Bio-Technology Co., Ltd.
|
| Tel: |
0510-85629785 18051595327; |
| Email: |
sales@hlsw-bio.com |
| Products Intro: |
Cas:665-66-7
ProductName:AMantadine Hydrochloride
Purity: 98% | Package: 25KG;1KG；500g,100g
|
- Amantadine
-
-
2026-09-18
- CAS:768-94-5
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 1000kg
- Amantadine HCl
-
-
2026-09-01
- CAS:665-66-7
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg
- Amantadine
-
- $10.70
-
2026-05-28
- CAS:281-23-2
- Min. Order: 10kg
- Purity: 99%
- Supply Ability: 10000kg
|
| | Amantadine Hcl Basic information |
| | Amantadine Hcl Chemical Properties |
| Melting point | >300 °C(lit.) | | Boiling point | 308.63°C (rough estimate) | | density | 1.0276 (rough estimate) | | refractive index | 1.6100 (estimate) | | storage temp. | Store below +30°C. | | solubility | H2O: 50 mg/mL | | form | Fine Crystalline Powder | | pka | 10.71 | | color | White | | Water Solubility | soluble | | Sensitive | Hygroscopic | | Merck | 14,374 | | BRN | 4198854 | | Major Application | pharmaceutical (small molecule) | | InChI | 1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H/t7-,8+,9-,10-; | | InChIKey | WOLHOYHSEKDWQH-UHFFFAOYSA-N | | SMILES | Cl[H].[H][C@@]12C[C@@]3([H])C[C@@]([H])(C1)CC(N)(C2)C3 | | LogP | -1.64 at 23℃ and pH6.3 | | CAS DataBase Reference | 665-66-7(CAS DataBase Reference) | | EPA Substance Registry System | Amantadine hydrochloride (665-66-7) |
| Hazard Codes | Xn | | Risk Statements | 22-40-20/21/22 | | Safety Statements | 22-36/37-36-35-20/21 | | RIDADR | UN 1759 8 / PGII | | WGK Germany | 3 | | RTECS | AU4375000 | | TSCA | TSCA listed | | HazardClass | IRRITANT | | HS Code | 29213000 | | Storage Class | 8A - Combustible corrosive hazardous materials | | Hazard Classifications | Acute Tox. 4 Oral | | Toxicity | LD50 orally in mice, rats: 700, 1275 mg/kg (Vernier) |
| | Amantadine Hcl Usage And Synthesis |
| Description | Amantadine Hcl is in a class of medications called adamantanes. It is thought to work to control movement problems by increasing the amount of dopamine in certain parts of the body. It works against influenza A virus by stopping the spread of the virus in the body. Amantadine is used to treat the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance) and other similar conditions. | | Uses | Amantadine Hcl is an antidyskinetic medicine. It is used to treat Parkinson's disease (sometimes called "paralysis agitans" or "shaking palsy") and its symptoms, including dyskinesia (sudden uncontrolled movements). It may be given alone or in combination with other medicines (eg, levodopa) for Parkinson's disease. By improving muscle control and reducing stiffness, this medicine allows more normal movements of the body as the disease symptoms are reduced. Amantadine is also used to treat stiffness and shakiness caused by certain medicines that are used to treat nervous, mental, and emotional conditions. | | Side effects | Blurred vision, nausea, stomach upset, drowsiness, dizziness, headache, dry mouth, constipation, nervousness, or trouble sleeping may occur. |
| | Amantadine Hcl Preparation Products And Raw materials |
|